Human papillomavirus vaccines

descriptionPublicationkeyboard_double_arrow_right Article 24 Sep 2017 English Publisher:CMA Joule Inc.Journal:Canadian Medical Association Journal, volume 189, pages E1212-E1212 (issn: 0820-3946, eissn: 1488-2329,

Copyright policy )

Authors: Shainoor J, Ismail; Shelley L, Deeks;

doi: 10.1503/cmaj.150465

pmid: 28947547

pmc: PMC5621933

Human papillomavirus vaccines

- Summary
- Subjects
- Metrics

Abstract

Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70% of

Related Organizations

Keywords

Human papillomavirus 16, Papillomavirus Infections, Humans, Immunotherapy, Active, Papillomavirus Vaccines

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average